Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Synagis Prescribers (US)

Articles with lock require a subscription to GLG News | Request a free trial
March 3, 2008
Gardasil for males--helping to fill in the gaps
Analysis of: Vaccinating Boys for Girls’ Sake? | www.nytimes.com
Author: GLG Expert Contributor
While the disease incidence (cervical carcinoma) is lower than many other cancers, thanks in part to successful screening, many of the remaining cases could be prevented by vaccinating EVERY female prior to the onset of sexual activity. Since this universal coverage is not likely, vaccinating males...
March 3, 2008
Just a transition stage
Analysis of: Google to store patients' health records | news.yahoo.com
Author: GLG Expert Contributor
Eventually, although not likely in the next ten years, electronic medical records (EMRs) will be the norm; once the interoperability issues are addressed, these records will be sharable across various networks. Until that time, systems such as Google's might serve some purpose.   &nb...
February 21, 2008
Attempting to address a major drawback of current treatments
Analysis of: Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia | pharmalive.com
Author: GLG Expert Contributor
The alpha adrfenergic side effects of current treatments for BPH are significantly limiting in the use of these drugs.
February 21, 2008
Focusing on the delivery system, not the drug
Analysis of: Phosphagenics Initiates US Clinical Trials For Its Topical Retinoic Acid | www.pipelinereview.com
Author: GLG Expert Contributor
Novel delivery systems will generally be the next wave, whether for topical medications such as retinoic acid or systemic compounds, where the delivery system can target specific receptors or organs.
February 15, 2008
Again, too simplistic an approach
Analysis of: Memphis Chosen by HHS as One Community to Help Create "Travelocity of Health Care" | www.memphis.bizjournals.com
Author: GLG Expert Contributor
Rating physicians is not like rating hotels, airlines or restaurants. Unfortunately, the comments of lay people can only go so far in assessing a physician's performance.
February 11, 2008
DPI for 4+ year olds - love it!
Analysis of: FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11 | www.pipelinereview.com
Author: GLG Expert Contributor
-Dry powder inhalers (DPIs) for kids are big news as traditional MDIs can be hard to use -If the device is easy to use, other meds (like albuterol) might be made available to use this way as well
February 7, 2008
Intriguing, but much more info needed
Analysis of: AIM Therapeutics Advances Asthma Therapeutics Program | www.pipelinereview.com
Author: GLG Expert Contributor
It would be great to be able to treat asthma and get steroid-like efficacy without the side effects. But there is not much to say without additional details.   
February 7, 2008
Preventive care again...just not a popular item in US Healthcare policy
Analysis of: CDC: Too few adults get their vaccines | news.yahoo.com
Author: GLG Expert Contributor
Vaccines have been shown again and again to be cost-effective tools. Fortunately, pediatric vaccines are generally given, since the schools enforce the requirements. But adults would benefit as well.
February 7, 2008
A good tool for children
Analysis of: FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11 | www.pipelinereview.com
Author: GLG Expert Contributor
Dry powder inhalers are easier for many young children to use than metered dose inhalers. This approval makes it possible to use a popular drug in younger patients who might not be able to use the MDI format.
February 4, 2008
Only very long-term studies will tell
Analysis of: Great Drug, but Does It Prolong Life? | www.nytimes.com
Author: GLG Expert Contributor
As is so often the case, the long-term benefits or risks of a particular therapy can only be evaluated by equally long-term studies. And the marketing and patent facts of life mean that drugs are released and pushed before all the data (or even sufficient data) is in, often with disastrous effects.

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next71 to 80 of 156

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T09:45:16.773